Five- and ten-year follow-up of medial unicompartmental knee arthroplasties in obese and non-obese patients.

Autor:	Gregor RH; Department of Orthopaedic Surgery, Christchurch Hospital, Christchurch, New Zealand., Hooper GJ; Department of Orthopaedic Surgery, Christchurch Hospital, Christchurch, New Zealand.; University of Otago, Dunedin, New Zealand., Frampton C; Department of Orthopaedic Surgery, Christchurch Hospital, Christchurch, New Zealand.
Jazyk:	angličtina
Zdroj:	Bone & joint open [Bone Jt Open] 2024 Oct 22; Vol. 5 (10), pp. 937-943. Date of Electronic Publication: 2024 Oct 22.
DOI:	10.1302/2633-1462.510.BJO-2024-0124.R1
Abstrakt:	Aims: The aim of this study was to determine whether obesity had a detrimental effect on the long-term performance and survival of medial unicompartmental knee arthroplasties (UKAs). Methods: This study reviewed prospectively collected functional outcome scores and revision rates of all medial UKA patients with recorded BMI performed in Christchurch, New Zealand, from January 2011 to September 2021. Patient-reported outcome measures (PROMs) were the primary outcome of this study, with all-cause revision rate analyzed as a secondary outcome. PROMs were taken preoperatively, at six months, one year, five years, and ten years postoperatively. There were 873 patients who had functional scores recorded at five years and 164 patients had scores recorded at ten years. Further sub-group analysis was performed based on the patient's BMI. Revision data were available through the New Zealand Joint Registry for 2,323 UKAs performed during this time period. Results: Obese patients (BMI > 30 kg/m 2 ) were 3.1 years younger than non-obese patients (BMI < 30 kg/m 2 ) at the time of surgery (mean age of obese patients 65.5 years (SD 9.7) and mean age of non-obese patients 68.6 years (SD 10.1)). Preoperatively, obese patients tended to have significantly lower functional scores than non-obese patients, which continued at five and ten years postoperatively. At these timepoints, obese patients had significantly lower scores for most PROMs measured compared to non-obese patients. However, there was no significant difference in the improvement of any of these scores after surgery between obese and non-obese patients. There was no significant difference in revision rates between obese and non-obese patients at any time. All-cause revision rate for obese patients was 0.73 per 100 observed component years compared to 0.67 in non-obese patients at ten years. There was also no significant difference in the aseptic loosening rate between groups. Conclusion: Our study supports the use of UKAs in obese patients, with similar benefit and survival compared to non-obese patients at ten years. Competing Interests: G. Hooper is Chairman of the New Zealand Joint Registry Trust. (© 2024 Gregor et al.)
Databáze:	MEDLINE
Externí odkaz:	Zobrazit plný text záznamu